Evozyne is transforming drug development with its AI-powered protein engineering platform, enabling researchers to design novel proteins, predict function, and optimize therapeutic candidates. The platform's machine learning models analyze protein sequences, simulate evolution, and support rational protein design for complex diseases. Evozyne collaborates with pharmaceutical companies, biotech firms, and academic researchers, advancing projects in rare diseases, oncology, and metabolic disorders. With robust data security, scalable infrastructure, and continuous innovation, Evozyne is advancing the science of protein-based therapeutics. SEO keywords: "Evozyne AI drug discovery," "AI protein engineering platform," "protein evolution drug design," "AI therapeutic protein optimization," "Evozyne innovation."